Agopian J, Navarro JM, Gac AC, Lecluse Y, Briand M, Grenot P, Gauduchon P, Ruminy P, Lebailly P, Nadel B, Roulland S. Agricultural pesticide exposure and the molecular connection to lymphomagenesis. J Exp Med. 2009 ;206:1473-83.
———————————————————————————————————————————————————
Aide N, Heutte N, Rame JP, Rousseau E, Henry-Amar M, Bardet S. Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation 131I scintigraphy for thyroid cancer. J Clin Endocrinol Metabol 2009;94(6):2075-2784.
———————————————————————————————————————————————————
Babin E, Beynier D, Le Gall D, Hitier M. Psychosocial quality of life in patients after total laryngectomy. Rev Laryngol Otol Rhinol (Bord). 2009;130(1):29-34.
———————————————————————————————————————————————————
Borie F, Niampa H, Bouvier AM, Faivre J, Launoy G, Delafosse P, Velten M, Buemi A, Peng J, Grosclaude P, Trétarre B. Current management and prognosis of intrahepatic cholangiocarcinoma in France. Gastroenterol Clin Biol 2009 ;33 (10-11):971-976.
———————————————————————————————————————————————————
Borie F, Trétarre B, Bouvier AM, Faivre J, Binder F, Launoy G, Delafosse P, Tissot J, Peng J, Grosclaude P, Guizard AV, Gras-Aygon C. Primary liver cancers : epidemiology and geographical study in France. Eur J Gastroenterol hepatol 2009;21(9):984-9.
———————————————————————————————————————————————————
Bouvier AM, Remontet L, Hédelin G, Launoy G, Jooste V, Grosclaude P, Belot A, Estève J, Bossard N, Faivre J. Conditional relative survival of cancer patients and annual excess risk of death. A French national database analysis. Cancer 2009;115(19) : 4616-24
———————————————————————————————————————————————————
Cadranel J, Quoix E, Baudrin L, Mourlanette P, Moro-Sibilot D, Morere Jf, Souquet Pj, Soria Jc, Morin F, Milleron B ; IFCT-0401 Trial Group. IFCT-0401 Trial : a phase II study of gefitinib administered as first-line treatment in advanced adenocarcinoma with bronchioloalveolar carcinoma subtype. J Thorac Oncol. 2009 Sep;4(9):1126-35.
———————————————————————————————————————————————————
Clin B, Morlais F, Guittet L, Gislard A, Marquignon M, Paris C, Caillard J, Launoy G, Letourneux M. Performance of chest radiograph and CT scan for lung cancer screening in asbestos-exposed workers. Occup Environ Med, 2009, 66(8), 529–534,
———————————————————————————————————————————————————
Clin B, Ferrant O, Marquignon MF, Letourneux M. Comparative analysis of medico legal compensation for occupational cancers in France and other western European countries: development proposal. Med Law 2009;28(4):615-676.
———————————————————————————————————————————————————
Clin B, Gournay M, Letourneux M, Marquignon MF, Papin F, Ferrant O, Launoy G. The french medico-legal concept of aptitude and fitness appraisal by occupational physicians: an ethical issue. Med Law 2009;28(2):317-336.
———————————————————————————————————————————————————
Clin B, Morlais F, Dubois B, Guizard A, Desoubeaux N, Marquignon M, Raffaelli C, Paris C, Galateau-Salle F, Launoy G, Letourneux M. Cohort study : Occupational asbestos exposure and digestive cancers. Alimentary Pharmacology & therapeutics, 2009, 30(4), 364–374,
———————————————————————————————————————————————————
Clin B, Morlais F, Guittet L, Gislard A, Marquignon MF, Paris C, Caillard JF, Launoy G, Letourneux M. Performance of chest radiograph and ct scan for lung cancer screening in asbestos-exposed workers. Occupationnal Environnemental Medicine 2009;66(8):529-34 Impact Factor: 3,020 Rang: Q1
———————————————————————————————————————————————————
Daubriac J, Fleury-Feith J, Kheuang L, Galipon J, Saint-Albin A, Renier A, Giovannini M, Galateau-Sallé F, Jaurand MC. Malignant pleural mesothelioma cells resist anoikis as quiescent pluricellular aggregates. Cell Death Differ. 2009 Aug;16(8):1146-55.
———————————————————————————————————————————————————
Favier O, Heutte N, Stamatoullas-Bastard A, Carde P, Van’t Veer MB, Aleman BM, Noordijk EM, Thomas J, Ferm´e C, Henry-Amar M; European Organization for Research and Treatment ofCancer (EORTC) Lymphoma Group and the Groupe d’Etudes des Lymphomes de l’Adulte (GELA). Survival after Hodgkin lymphoma : causes of death and excess mortality in patients treated in 8 consecutive trials.Cancer. 2009; 115 :1680-91.
———————————————————————————————————————————————————
Garsi JP, Schlumberger M, Ricard M, Labbé M, Ceccarelli C, Schvartz C, Henry-Amar M, Bardet S, Rubino C, de Vathaire F. Health outcomes of children fathered by patients treated with radioiodine for thyroid cancer. Clin Endocrinol 2009;71(6):880-883.
———————————————————————————————————————————————————
Gatta G, Zigon G, Buemi A, Coebergh JW, Colonna M, Contiero P, Denis L, Grosclaude P, Guizard AV, Sanchez-Perez MJ, Plesko I, Ondrusova M, Rachtan J,Valdagni R, Velten M, Vercelli M, Berrino F. Prostate cancer treatment in Europe at the end of 1990s. Acta Oncol. 2009;48(6):867-73.
———————————————————————————————————————————————————
Guittet L, Bouvier V, Mariotte N, Vallee JP, Levillain R, Tichet J, Launoy G. Performances of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples. Int J Cancer 2009;125(5):1127-33.
———————————————————————————————————————————————————
Guittet L, Bouvier V, Mariotte N, Vallee JP, Levillain R, Tichet J, Launoy G. Comparison of a guaiac and an immunochemical faecal occult blood test in detection of colonic lesions according to lesion type and location. British Journal of Cancer 2009 Apr 21;100(8):1230-5.
———————————————————————————————————————————————————
Haas RL, Girinsky T, Aleman BM, Henry-Amar M, de Boer JP, de Jong D. Low-dose involved-field radiotherapy as alternative treatment of nodular lymphocyte predominance Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 2009;74(4):1199-1202.
———————————————————————————————————————————————————
Heutte N, Flechtner HH, Mounier N, Mellink WAM, Meerwaldt JH, Eghbali H, van’t Veer MB, Noordijk EM, Kluin-Nelemans JC, Lampka E, Thomas J, Lugtenburg PJ, Viterbo L, Carde P, Hagenbeek A, van der Maazen RWM, Smit WGJM, Brice P, van Marwijk Kooy M, Baars JW, Poortmans P, Tirelli U, Leeksma OC, Tomšič R, Feugier P, Salles G, Gabarre J, Kersten MJ, van den Neste E, Creemers GJM, Gaillard I, Meijnders P, Tertian G, Reman O, Muller HP, Troncy J, Blanc M, Schroyens W, Voogt PJ, Wijermans P, Rieux C, Fermé C, Henry-Amar M, for the EORTC-GELA H8 Trial. Quality of life after successful treatment of early-stage Hodgkin lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial. Lancet Oncol 2009;10:1160-1170.
———————————————————————————————————————————————————
Husain AN, Colby TV, Ordóñez NG, Krausz T, Borczuk A, Cagle PT, Chirieac LR, Churg A, Galateau-Salle F, Gibbs AR, Gown AM, Hammar SP, Litzky LA, Roggli VL, Travis WD, Wick MR. Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2009 Aug;133(8):1317-31.
———————————————————————————————————————————————————
Italiano A, Ortholan C, Oudard S, Pouessel D, Gravis G, Beuzeboc P, Bompas E, Fléchon A, Joly F, Ferrero JM, Fizazi K. Docetaxel-based chemotherapy in elderly patients (age 75 and older) with castration-resistant prostate cancer. Eur Urol. 2009 Jun;55(6):1368-75.
———————————————————————————————————————————————————
Joly F, Houédé N, Noal S, Chevreau C, Priou F, Chinet-Charrot P, Rolland F, Fléchon A, Henry-Amar M, Culine S. Do patients with advanced urothelial carcinoma benefit from weekly paclitaxel chemotherapy? A GETUG phase II study. Clin Genitourin Cancer 2009 Aug 1;7(2):E28-E33.
———————————————————————————————————————————————————
Joly F, Petit T, Pautier P, Guardiola E, Mayer F, Chevalier-Place A, Delva R, Sevin E, Henry-Amar M, Bourgeois H. Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: A French multicenter phase II study. Gynecol Oncol 2009;115(3):382-388.
———————————————————————————————————————————————————
Joly-Lobbedez F. Chimioradiothérapie concomitante dans les cancers du col de l’utérus : quels niveaux de preuve ?Cancer Radiother 2009;13(6-7):503-6.
———————————————————————————————————————————————————
Labiche A, Elie N, Herlin P, Denoux Y, Crouet H, Heutte N, Joly F, Héron JF, Gauduchon P, Henry-Amar M. Prognostic significance of tumour vascularisation on survival of patients with advanced ovarian carcinoma. Histol Histopathol 2009;24(4):425-435.
———————————————————————————————————————————————————
Lanier C, Heutte N, Richard E, Bouchart V, Lebailly P, Garon D. Mycoflora and mycotoxin production in oilseed cakes during farm storage. J Agric Food Chem. 2009; 57 :1640-5.
———————————————————————————————————————————————————
Launoy G, Dejardin O; Social and geographical inequalities in cancer care. Beyond observation? Bulletin du cancer; 96(iss3); s13-s15
———————————————————————————————————————————————————
Launoy G. Improvement in screening for colorectal cancer associated with the use of immunochemical faecal occult blood test. Pathologie Biologie.2009 ;57 :488–492
———————————————————————————————————————————————————
Lebailly P, Bouchart V, Baldi I, Lecluse Y, Heutte N, Gislard A, MalasJP. Exposure to pesticides in open-field farming in France.Ann Occup Hyg. 2009;53 :69-81.
———————————————————————————————————————————————————
Lecluse Y, Lebailly P, Roulland S, Gac AC, Nadel B, Gauduchon P. t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals. Leukemia. 2009 ;23:1190-3.
———————————————————————————————————————————————————
Lefebvre AC, Maurel J, Boutreux S, Bouvier V, Reimund JM, Launoy G, Arsene D. Pancreatic cancer: Incidence, treatment and survival trends – 1175 cases in Calvados (France) from 1978 to 2002.Gastroenterol Clin Biol 2009;33(10-11):1045-51
———————————————————————————————————————————————————
Leux C, Colonna M, Guizard AV, Uhry Z, Velten M, Ganry O, Schvartz C,Grosclaude P, Molinié F; le réseau Francim. Time trends in the geographicvariation of thyroid cancer incidence by tumor size from 1983 to 2000 in France. Rev Epidemiol Sante Publique. 2009 Dec;57(6):403-10.
———————————————————————————————————————————————————
Mallet Y, Avalos N, Le Ridant AM, Gangloff P, Moriniere S, Rame JP, Poissonnet G, Makeieff M, Cosmidis A, Babin E, Barry B, Fournier C. Head and neck cancer in young people: a series of 52 SCCs of the oral tongue in patients aged 35 years or less. Acta Otolaryngol. 2009 Dec;129(12):1503-8.
———————————————————————————————————————————————————
Mallet Y, Avalos N, Ridant AM, Gangloff P, Moriniere S, Rame JP, Poissonnet G, Makeieff M, Cosmidis A, Babin E, Barry B, Fournier C. Head and neck cancer in young people: a series of 52 SCCs of the oral tongue in patients aged 35 years or less.Acta Otolaryngol. 2009 Mar 10:1-6.
———————————————————————————————————————————————————
van der Kaaij MA, Heutte N, van Echten-Arends J, Raemaekers JM, Carde P, Noordijk EM, Ferm´eC,Thomas J, EghbaliH, Brice P, Bonmati C, Henry-Amar M, Kluin-Nelemans HC. Sperm quality before treatment in patients with early stage Hodgkin’s lymphoma enrolled in EORTC-GELA Lymphoma Group trials. Haematologica. 2009; 94 :1691-7.
———————————————————————————————————————————————————
Vlastos F, Hillas G, Vidal P, Lacomme S, Galateau-Sallé F, Vollmer E, Guzman-Costabel J, Vignaud JM, Martinet N. Survey and biological insights of pemetrexed-related therapeutic improvement in mesothelioma: The Nancy Centre of Biological Resources’ Mesothelioma Cohort. J Thorac Oncol. 2009 Oct;4(10):1259-63.
———————————————————————————————————————————————————
Zalcman G, Bergot E. “EGFR gene copy number or mutations and survival in Non-Small Cell Lung Cancer (NSCLC) patients treated by EGFR tyrosine kinase inhibitors (TKI) » Lancet 2009, 373 : 541
———————————————————————————————————————————————————
Zalcman G, Bergot E. Gefitinib plus docetaxel in non-small-cell lung cancer. Lancet. 2009 Feb 14;373(9663):541
———————————————————————————————————————————————————
Zhang X, Varin E, Briand M, Allouche S, Heutte N, Schwartz L, Poulain L, Icard P. Novel therapy for malignant pleural mesothelioma based on anti-energetic effect : an experimental study using3-Bromopyruvate on nude mice. Anticancer Res. 2009; 29 :1443-8.
